These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 34555475)
1. 5-HT Solas M; Van Dam D; Janssens J; Ocariz U; Vermeiren Y; De Deyn PP; Ramirez MJ Neurochem Int; 2021 Nov; 150():105185. PubMed ID: 34555475 [TBL] [Abstract][Full Text] [Related]
2. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease. Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP J Alzheimers Dis; 2014; 41(3):819-33. PubMed ID: 24685637 [TBL] [Abstract][Full Text] [Related]
3. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study. Nazarali AJ; Reynolds GP Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363 [TBL] [Abstract][Full Text] [Related]
4. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease. Vermeiren Y; Janssens J; Aerts T; Martin JJ; Sieben A; Van Dam D; De Deyn PP J Alzheimers Dis; 2016 Jun; 53(3):1079-96. PubMed ID: 27314528 [TBL] [Abstract][Full Text] [Related]
5. Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease. Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; De Deyn PP Neurobiol Aging; 2014 Dec; 35(12):2691-2700. PubMed ID: 24997673 [TBL] [Abstract][Full Text] [Related]
6. Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's Disease. Werner FM; Covenas R Curr Pharm Des; 2016; 22(14):2064-71. PubMed ID: 26818863 [TBL] [Abstract][Full Text] [Related]
7. Serotonergic system, cognition, and BPSD in Alzheimer's disease. Chakraborty S; Lennon JC; Malkaram SA; Zeng Y; Fisher DW; Dong H Neurosci Lett; 2019 Jun; 704():36-44. PubMed ID: 30946928 [TBL] [Abstract][Full Text] [Related]
8. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Pandey GN; Dwivedi Y; Rizavi HS; Ren X; Pandey SC; Pesold C; Roberts RC; Conley RR; Tamminga CA Am J Psychiatry; 2002 Mar; 159(3):419-29. PubMed ID: 11870006 [TBL] [Abstract][Full Text] [Related]
9. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Hellström-Lindahl E; Mousavi M; Zhang X; Ravid R; Nordberg A Brain Res Mol Brain Res; 1999 Mar; 66(1-2):94-103. PubMed ID: 10095081 [TBL] [Abstract][Full Text] [Related]
10. The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease. Vermeiren Y; Van Dam D; Aerts T; Engelborghs S; Martin JJ; De Deyn PP Alzheimers Res Ther; 2015; 7(1):7. PubMed ID: 25717350 [TBL] [Abstract][Full Text] [Related]
11. Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. Mahé C; Loetscher E; Dev KK; Bobirnac I; Otten U; Schoeffter P Neuropharmacology; 2005 Jul; 49(1):40-7. PubMed ID: 15992579 [TBL] [Abstract][Full Text] [Related]
12. Investigation of the Role of Stimulation and Blockade of 5-HT Dincer B; Halici Z; Cadirci E J Mol Neurosci; 2021 May; 71(5):1095-1111. PubMed ID: 33200380 [TBL] [Abstract][Full Text] [Related]
13. Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. Béïque JC; Campbell B; Perring P; Hamblin MW; Walker P; Mladenovic L; Andrade R J Neurosci; 2004 May; 24(20):4807-17. PubMed ID: 15152041 [TBL] [Abstract][Full Text] [Related]
14. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. Cohen Z; Bouchelet I; Olivier A; Villemure JG; Ball R; Stanimirovic DB; Hamel E J Cereb Blood Flow Metab; 1999 Aug; 19(8):908-17. PubMed ID: 10458598 [TBL] [Abstract][Full Text] [Related]
15. MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7. Zhu H; Xiao X; Chai Y; Li D; Yan X; Tang H Biochem Biophys Res Commun; 2019 Apr; 511(3):671-678. PubMed ID: 30827505 [TBL] [Abstract][Full Text] [Related]
16. A 5-HT(7) receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization. Chapin EM; Andrade R J Pharmacol Exp Ther; 2001 Apr; 297(1):395-402. PubMed ID: 11259568 [TBL] [Abstract][Full Text] [Related]
17. Serotonin (5-HT) in brains of adult patients with Down syndrome. Seidl R; Kaehler ST; Prast H; Singewald N; Cairns N; Gratzer M; Lubec G J Neural Transm Suppl; 1999; 57():221-32. PubMed ID: 10666678 [TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. Bi H; Sze CI J Neurol Sci; 2002 Aug; 200(1-2):11-8. PubMed ID: 12127670 [TBL] [Abstract][Full Text] [Related]
19. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care. Trillo L; Das D; Hsieh W; Medina B; Moghadam S; Lin B; Dang V; Sanchez MM; De Miguel Z; Ashford JW; Salehi A Neurosci Biobehav Rev; 2013 Sep; 37(8):1363-79. PubMed ID: 23707776 [TBL] [Abstract][Full Text] [Related]
20. The effects of the 5-HT7 receptor on hippocampal long-term potentiation and apoptosis in a rat model of Alzheimer's disease. Hashemi-Firouzi N; Komaki A; Soleimani Asl S; Shahidi S Brain Res Bull; 2017 Oct; 135():85-91. PubMed ID: 28987281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]